Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Bonesupport

196,10 SEK

+0,87 %

Mindre end 1K følgere

BONEX

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
+0,87 %
+15,83 %
+4,31 %
+8,16 %
-35,58 %
-39,88 %
+145,13 %
+241,64 %
+512,81 %

Bonesupport operates in the medical technology industry and focuses on the development and manufacture of bioceramic implants for bone repair and reconstruction. The company's products are aimed at surgeons and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. Bonesupport was founded in 1999 and is headquartered in Lund, Sweden.

Læs mere
Markedsværdi
13,09 mia. SEK
Aktieomsætning
206,27 mio. SEK
Omsætning
1,17 mia.
EBIT %
19,72 %
P/E
90,79
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mia.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
22.4
2026

Delårsrapport Q1'26

12.5
2026

Generalforsamling '26

16.7
2026

Delårsrapport Q2'26

Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse6.3.2026, 13.10

US Clinical Data Highlight CERAMENT® G in Infection Prevention for Trauma Patients

Bonesupport
Pressemeddelelse27.2.2026, 13.45

Published US Pilot Study Highlights Clinical Experience with CERAMENT® G in Trauma

Bonesupport
Pressemeddelelse26.2.2026, 08.42

Redeye: BONESUPPORT (Q4 Review): Entering a 2026 full of inflexion points

Bonesupport

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Bonesupport, Audiocast, Year end report, 2025
Videopræsentation24.2.2026, 09.00

Bonesupport, Audiocast, Year end report, 2025

Bonesupport
Selskabsmeddelelse24.2.2026, 07.00

BONESUPPORT HOLDING AB (publ) – publishes year-end report 2025

Bonesupport
Pressemeddelelse19.2.2026, 15.00

Modular Finance IR Consensus: BONESUPPORT – Consensus estimates Q4 2025

Bonesupport
Pressemeddelelse17.2.2026, 08.47

BONESUPPORT HOLDING AB (publ) – Invitation to Conference Call and Webcast for Year-End Report 2025

Bonesupport
Selskabsmeddelelse13.1.2026, 16.35

BONESUPPORT HOLDING AB (publ) announces Q4 2025 revenue and provides 2026 outlook

Bonesupport
Selskabsmeddelelse2.12.2025, 07.13

CERAMENT® V application in the U.S. transferred to the De Novo process

Bonesupport
Pressemeddelelse31.10.2025, 15.40

BONESUPPORT HOLDING AB (publ) – Correction in Q3 2025 interim report

Bonesupport
Pressemeddelelse24.10.2025, 07.12

Redeye: BONESUPPORT (Q3 Review) - Still just getting started

Bonesupport
Bonesupport, Audiocast, Q3'25
Videopræsentation23.10.2025, 08.00

Bonesupport, Audiocast, Q3'25

Bonesupport
Selskabsmeddelelse23.10.2025, 06.00

BONESUPPORT HOLDING AB (publ) – publishes Q3 2025 Interim report

Bonesupport
Pressemeddelelse20.10.2025, 12.15

Modular Finance IR Consensus: BONESUPPORT – Consensus estimates Q3 2025

Bonesupport
Pressemeddelelse16.10.2025, 06.00

BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2025

Bonesupport
Pressemeddelelse16.9.2025, 06.50

No infection recurrence when using CERAMENT® G in infected hip implant management

Bonesupport
Pressemeddelelse15.9.2025, 07.40

Strong CERAMENT® Results Presented at EBJIS

Bonesupport
Selskabsmeddelelse12.8.2025, 14.51

CMS APPROVES NTAP FOR CERAMENT® G IN OPEN FRACTURES, PROVIDING ADDITIONAL HOSPITAL REIMBURSEMENT STARTING OCTOBER 1, 2025

Bonesupport
Pressemeddelelse30.7.2025, 07.42

ANNOUNCED INSIDER TRADING

Bonesupport
Pressemeddelelse16.7.2025, 08.20

Redeye: BONESUPPORT Q2 - Still puttin’ on the ritz

Bonesupport
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.